Literature DB >> 28053211

Optical Screening for Rapid Antimicrobial Susceptibility Testing and for Observation of Phenotypic Diversity among Strains of the Genetically Clonal Species Bacillus anthracis.

Heather P McLaughlin1, Amy S Gargis1, Pierre Michel1, David Sue1, Linda M Weigel2.   

Abstract

During high-impact events involving Bacillus anthracis, such as the Amerithrax incident of 2001 or the anthrax outbreaks in Russia and Sweden in 2016, critical decisions to reduce morbidity and mortality include rapid selection and distribution of effective antimicrobial agents for treatment and postexposure prophylaxis. Detection of antimicrobial resistance currently relies on a conventional broth microdilution method that requires a 16- to 20-h incubation time for B. anthracis Advances in high-resolution optical screening offer a new technology to more rapidly evaluate antimicrobial susceptibility and to simultaneously assess the growth characteristics of an isolate. Herein, we describe a new method developed and evaluated as a rapid antimicrobial susceptibility test for B. anthracis This method is based on automated digital time-lapse microscopy to observe the growth and morphological effects of relevant antibiotics with an optical screening instrument, the oCelloScope. B. anthracis strains were monitored over time in the presence or absence of penicillin, ciprofloxacin, or doxycycline. Susceptibility to each antibiotic was determined in ≤4 h, 75 to 80% less than the time required for conventional methods. Time-lapse video imaging compiled from the optical screening images revealed unexpected differences in growth characteristics among strains of B. anthracis, which is considered to be a clonal organism. This technology provides a new approach for rapidly detecting phenotypic antimicrobial resistance and for documenting growth attributes that may be beneficial in the further characterization of individual strains.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Bacillus anthracis; morphological differentiation; multidrug resistance; optical screening technology

Mesh:

Substances:

Year:  2017        PMID: 28053211      PMCID: PMC5328465          DOI: 10.1128/JCM.02209-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Real-time optical antimicrobial susceptibility testing.

Authors:  Marlene Fredborg; Klaus R Andersen; Erik Jørgensen; Aida Droce; Tom Olesen; Bent B Jensen; Flemming S Rosenvinge; Teis E Sondergaard
Journal:  J Clin Microbiol       Date:  2013-04-17       Impact factor: 5.948

2.  A rapid antimicrobial susceptibility test for Bacillus anthracis.

Authors:  Linda M Weigel; David Sue; Pierre A Michel; Brandon Kitchel; Segaran P Pillai
Journal:  Antimicrob Agents Chemother       Date:  2010-05-03       Impact factor: 5.191

3.  In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones.

Authors:  I Brook; T B Elliott; H I Pryor; T E Sautter; B T Gnade; J H Thakar; G B Knudson
Journal:  Int J Antimicrob Agents       Date:  2001-12       Impact factor: 5.283

4.  Bacillus anthracis diversity in Kruger National Park.

Authors:  K L Smith; V DeVos; H Bryden; L B Price; M E Hugh-Jones; P Keim
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

5.  Selection of Bacillus anthracis isolates resistant to antibiotics.

Authors:  A Athamna; M Athamna; N Abu-Rashed; B Medlej; D J Bast; E Rubinstein
Journal:  J Antimicrob Chemother       Date:  2004-06-17       Impact factor: 5.790

6.  Phylogenetic discovery bias in Bacillus anthracis using single-nucleotide polymorphisms from whole-genome sequencing.

Authors:  Talima Pearson; Joseph D Busch; Jacques Ravel; Timothy D Read; Shane D Rhoton; Jana M U'Ren; Tatum S Simonson; Sergey M Kachur; Rebecca R Leadem; Michelle L Cardon; Matthew N Van Ert; Lynn Y Huynh; Claire M Fraser; Paul Keim
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-03       Impact factor: 11.205

7.  Genetic diversity in a Bacillus anthracis historical collection (1954 to 1988).

Authors:  David Sue; Chung K Marston; Alex R Hoffmaster; Patricia P Wilkins
Journal:  J Clin Microbiol       Date:  2007-03-28       Impact factor: 5.948

8.  Differentiation of Bacillus anthracis from other Bacillus cereus group bacteria with the PCR.

Authors:  I Henderson; C J Duggleby; P C Turnbull
Journal:  Int J Syst Bacteriol       Date:  1994-01

9.  Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare.

Authors:  M E Jones; J Goguen; I A Critchley; D C Draghi; J A Karlowsky; D F Sahm; R Porschen; G Patra; V G DelVecchio
Journal:  Clin Microbiol Infect       Date:  2003-09       Impact factor: 8.067

10.  [Comparison of therapeutic effects of antibiotics of the tetracycline group in the treatment of anthrax caused by a strain inheriting tet-gene of plasmid pBC16].

Authors:  A P Pomerantsev; N A Shishkova; L I Marinin
Journal:  Antibiot Khimioter       Date:  1992-04
View more
  2 in total

1.  Rapid antimicrobial susceptibility testing and β-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening.

Authors:  Heather P McLaughlin; David Sue
Journal:  BMC Microbiol       Date:  2018-12-18       Impact factor: 3.605

2.  Rapid Detection of Genetic Engineering, Structural Variation, and Antimicrobial Resistance Markers in Bacterial Biothreat Pathogens by Nanopore Sequencing.

Authors:  Amy S Gargis; Blake Cherney; Andrew B Conley; Heather P McLaughlin; David Sue
Journal:  Sci Rep       Date:  2019-09-18       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.